Category: DaVita Inc.Syndicate content

B. Braun, DaVita ink supply deal

November 21, 2013 by Chris Walker

B. Braun inked a supply deal for Davita's dialysis products.

B. Braun, DaVita ink supply deal

B. Braun Medical said it's entered an agreement with DaVita to provide its Dialog+ dialysis equipment to fill a portion of DaVita's product requirement.

Bethlehem, Pa.-based Braun has been a leader in the dialysis field for years and has a long-standing relationship with DaVita. The Dialog+ system allows patients to have the greatest number of possible configurations for individual treatment.

DaVita gets in on $12M round for CVRx

November 1, 2013 by Chris Walker

CVRx adds $12 million from DaVita HealthCare and others to its $42 million Series F round.

DaVita  gets in on $12M round for CVRx

CVRx said it added $12 million from DaVita HealthCare, Ysios Capital and others to its Series F funding round, taking the total for the round to $42 million.

The Minneapolis-based company is planning to use the money to advance clinical trials and expand its international commercial footprint, according to a press release. CVRx developed the Barostim Neo, a pacemaker-like device designed to treat hypertension.

Medicare's proposed dialysis cut takes a toll on device makers

July 2, 2013 by Arezu Sarvestani

Medical device makers DaVita and Fresenius suffer Wall Street losses amid Medicare's proposal to cut about 9% from dialysis reimbursements.

Updated July 2, 2013, at 3:45 p.m. with comment from NxStage Medical.

Updated July 2, 2013, at 5 p.m. with comment from Fresenius.

healthcare and spending

Dialysis technology makers slid hard today after the Center for Medicare & Medicaid Services proposed a reimbursement decrease of more than 9% for 2014.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Sunshine Heart seeks $25.5M in equity funding round | Wall Street Beat

May 24, 2013 by Arezu Sarvestani

Sunshine Heart raises $1.5 million of a hoped-for $25.5 million equity funding round. Wall Street Beat

Eden Prairie, Minn., and Sydney-based medical device company Sunshine Heart (ASX:SHC) is looking to raise funds in a $25.5 million equity funding round, according to document filed with the SEC earlier this month.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Hamilton Thorne names new CEO | Personnel Moves

September 7, 2011 by MassDevice staff

Hamilton Thorne puts a new man in the corner office after his two-year term as company president.

Hamilton Thorne

Laser-based lab equipment maker Hamilton Thorne Inc. (TSX-V: HTL) has named company president David Wolf as CEO.  Wolf takes over the post from company co-founder Meg Spencer, who will remain with Hamilton Thorne as chairman of the board and a chief strategic advisor.

Wolf, who helped take the company public, has been president of the Hamilton Thorne since 2009 and will continue to hold that role along with the additional CEO responsibilities.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Green med-tech: Becton Dickinson and Davita team up with Waste Management to recycle dialysis waste

August 10, 2011 by MassDevice staff

Becton Dickinson and Davita join forces with Waste Management to launch the first U.S. dialyzer recycling pilot in Southern California.

Updated: 8/11/2011 1:15 p.m.

Becton Dickinson
Waste Management

Kidney care services provider DaVita Inc. (NYSE:DVA) is taking on the environmental footprint left by its customers by launching a pilot program to recycle some of the waste from dialysis centers.

Allergan beats and raises on 14 percent boost in sales | Earnings Roundup

August 8, 2011 by MassDevice staff

Allergan boasts strong sales growth in Q2, but sales are sluggish for its weight-loss gastric banding devices.


Allergan Inc. (NYSE:AGN) touted a strong quarter on the back on growing sales.

The Irvine, Calif.-based company saw strong growth in revenue in the three months ended June 30, posting $1.4 billion in sales, which amounts to a 14 percent increase over $1.2 billion in sales reporting during the same time last year.

Device sales jumped 12 percent to $245 million for the quarter, compared to $219 million in Q2 2010.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp